Peter R. Galle - Researcher Profile | RDL Research Database

Publications

4 shown

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

María Reig , Alejandro Forner , Jordi Rimola +13 more

2021 Journal of Hepatology 3634 citations

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle , Alejandro Forner , Josep M. Llovet +5 more

2018 Journal of Hepatology 11069 citations

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

Christoph Becker , Massimo Claudio Fantini , Christoph Schramm +15 more

2004 Immunity 711 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 21,878
Institution: European Association for the Study of the Liver

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8294-0992

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.